US Stocks
/
Moleculin Biotech, Inc. Share Price

Moleculin Biotech, Inc. Share Price

NASDAQ: MBRX
$0.43
+$0.02 (6.15%) Last updated on 11 Aug, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Moleculin Biotech, Inc. Stock Performance

Open
$0.41
Prev. Close
$0.41
Circuit Range
N/A
Day Range
$0.41 - $0.46
Year Range
$0.16 - $7.84
Volume
28,497
Average Traded
$0.44

Moleculin Biotech, Inc. Share Price Today

As of 11 August 2026, Moleculin Biotech, Inc.'s share price is $0.43. The stock opened at $0.41, compared to its previous close of $0.41. During today's trading session, Moleculin Biotech, Inc.'s share price traded between $0.41 and $0.46, with an average price of $0.44. Over the past 52 weeks, the stock has recorded a high of $7.84 and a low of $0.16. In terms of performance, Moleculin Biotech, Inc.'s share price has declined by 82.09% over the last six months and is up 9.57% on a year-on-year basis.

Moleculin Biotech, Inc. Share Price Chart

$0.41$0.46
L
Show Current Price
H

Moleculin Biotech, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00
Net Profit-$4.97M-$4.32M-$10.59M-$6.44M-$7.64M-$25.40M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A13.10%-145.24%39.24%-18.71%-232.45%

About Moleculin Biotech, Inc.

Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose for the treatment of pathogenic viruses and various cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas.

Moleculin Biotech, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.34
$0.41
+2.25%
Jul 2026
$2.62
$0.40
-85.69%
Jun 2026
$2.85
$2.79
+0.18%
May 2026
$2.51
$2.79
+8.98%
Apr 2026
$2.25
$2.56
+12.78%
Mar 2026
$2.42
$2.27
-5.81%
Feb 2026
$4.30
$2.41
-42.96%
Jan 2026
$3.32
$4.22
+28.22%
Dec 2025
$6.29
$3.29
+1,124.91%
Nov 2025
$0.46
$0.27
-42.40%
Oct 2025
$0.55
$0.47
-11.22%
Sep 2025
$0.38
$0.53
+33.50%

MBRX Share Price FAQs

What is Moleculin Biotech, Inc. share price today?

chevron-up
Moleculin Biotech, Inc. share price today is $0.43 as on August 11, 2026 at 1:23 am IST.

What is the 52 week high and 52 week low of Moleculin Biotech, Inc. stock?

chevron-up
The 52 week high of Moleculin Biotech, Inc. stock is $7.84, while the 52 week low is $0.16 as of 11 Aug '26.

What is MBRX's net income for the last quarter?

chevron-up
MBRX's net income for the last quarter is -0.03B USD.

What is the 5 year returns of MBRX?

chevron-up
The 5 year returns of MBRX is -99.07% as on 11 Aug '26.

What is the high & low stock price of MBRX today?

chevron-up
MBRX stock price hit a high of $0.46 and low of $0.41 as of 11 Aug '26.

Can I buy MBRX shares in India?

chevron-up
Yes. You can buy MBRX in India by opening an international trading account.